FOLAKE OREHIN: Open Payments
NPI 1619582087 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $55 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $80 |
| Lilly USA, LLC | 2 | $52 |
| Novo Nordisk Inc | 2 | $43 |
| Exact Sciences Corporation | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| PFIZER INC. | 1 | $15 |
Products named: Cologuard Collection Kit, NEXLETOL, XIFAXAN, Ozempic, ZEPBOUND, MOUNJARO, Yeztugo, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
